BruceEvanJohnsonMD

PubMed

• 1 citations
  Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
  Vaz, V., Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao V Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr...> ;Journal of Clinical Oncology. 2024 Apr 10
• A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
  Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
• A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity.
  Patel, A., Ashenberg, O., Collins, N., Segerstolpe, Å., Jiang, S., Slyper, M., Huang, X., Caraccio, C., Jin, H., Sheppard, H., Xu, K., Chang, T., Orr, B., Shirinifard,...> ;Biorxiv. 2024 Jan 16
• Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Dec 14
• 5 citations
  Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
  Taylor, M., Wu, C., Fridy, P., Zhang, S., Senussi, Y., Wolters, J., Cajuso, T., Cheng, W., Heaps, J., Miller, B., Mori, K., Cohen, L., Jiang, H., Molloy, K., Chait, B....> ;Cancer Discovery. 2023 Dec 12
• Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study.
  Dacic, S., Travis, W., Giltnane, J., Kos, F., Abel, J., Hilz, S., Fujimoto, J., Sholl, L., Ritter, J., Khalil, F., Liu, Y., Taylor-Weiner, A., Resnick, M., Yu, H., Hir...> ;Journal of Thoracic Oncology. 2023 Dec 7
• 3 citations
  Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
  Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny...> ;Journal of Clinical Oncology. 2024 Jan 10
• 1 citations
  Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Nov 18
• 1 citations
  Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
  Joao V Alessi, Adam Price, Allison L Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief, Federica Pecci, Alessandro Di Federico, Malini M Gandhi, Emily S Lebow, Pa...> ;Journal for Immunotherapy of Cancer. 2023 Nov 1
• 3 citations
  Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC.
  Vaz, V., Joao V Alessi, Xinan Wang, Arielle Elkrief, Biagio Ricciuti, Yvonne Y Li, Hersh Gupta, Liam F Spurr, Hira Rizvi, Jia Luo, Federica Pecci, Giuseppe Lamberti, G...> ;Journal of Thoracic Oncology. 2023 Nov 1
• Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
  Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Ma...> ;Nature Medicine. 2024 Jan 1
• 4 citations
  Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC.
  Joao V Alessi, Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Arielle Elkrief, Scott J Rodig, Emily S Lebow, Jordan E Eicholz,...> ;Nature Communications. 2023 Jul 15
• 6 citations
  Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With-Mutant Metastatic Non-Small-Cell Lung Cancer.
  Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Micha...> ;Journal of Clinical Oncology. 2023 Jul 20
• 12 citations
  Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC.
  Vaz, V., Joao V Alessi, Arielle Elkrief, Biagio Ricciuti, Xinan Wang, Alessio Cortellini, Victor R Vaz, Giuseppe Lamberti, Rosa L Frias, Deepti Venkatraman, Claudia A ...> ;Journal of Thoracic Oncology. 2023 Jun 1
• 3 citations
  Acquiring tissue for advanced lung cancer diagnosis and comprehensive biomarker testing: A National Lung Cancer Roundtable best-practice guide.
  Adam H Fox, Mizuki Nishino, Raymond U Osarogiagbon, M Patricia Rivera, Lauren S Rosenthal, Robert A Smith, Farhood Farjah, Lynette M Sholl, Gerard A Silvestri, Bruce E...> ;CA. 2023 Mar 1
• Tumor Volume Nadir in Patients With-Rearranged Non-Small-Cell Lung Cancer Treated With Alectinib.
  Mizuki Nishino, Zihan Wei, Emanuele Mazzola, Takuya Hino, Shu-Chi Tseng, Michelle E Sanchez, Hiroto Hatabu, Bruce E Johnson, Mark M Awad> ;JCO Precision Oncology. 2023 Mar 1
• 5 citations
  Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.
  Lorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, Alyaa Al-Ibraheemi, Hersh Gupta, Yvonne Y Li, Harrison K Tsai, Wenjun Kang, Abigail Ward, Alanna J Church, AeRang ...> ;JCO Precision Oncology. 2022 Nov 1
• 1 citations
  Safety of image guided research biopsies in patients with thoracic malignancies.
  Steffan K Soosman, Matthew P Schenker, Emanuele Mazzola, Emma Voligny, Anna Smokovich, Camden Bay, Tom Nguyen, Kesi Michael, Pasi A Jänne, Michael Rabin, Daniel I Glaz...> ;Lung Cancer. 2022 Nov 1
• 7 citations
  Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoa...
  Valerie W Rusch, Alan Nicholas, G Alexander Patterson, Salama N Waqar, Eric M Toloza, Eric B Haura, Dan J Raz, Karen L Reckamp, Robert E Merritt, Dwight H Owen, David ...> ;The Journal of Thoracic and Cardiovascular Surgery. 2023 Mar 1
• 10 citations
  MatchMiner: an open-source platform for cancer precision medicine.
  Harry Klein, Tali Mazor, Ethan Siegel, Pavel Trukhanov, Andrea Ovalle, Catherine Del Vecchio Fitz, Zachary Zwiesler, Priti Kumari, Bernd Van Der Veen, Eric Marriott, J...> ;NPJ Precision Oncology. 2022 Oct 6
• 76 citations
  Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
  Jamie E Chaft, Filiz Oezkan, Mark G Kris, Paul A Bunn, Ignacio I Wistuba, David J Kwiatkowski, Dwight H Owen, Yan Tang, Bruce E Johnson, Jay M Lee, Gerard Lozanski, Ma...> ;Nature Medicine. 2022 Oct 1
• 16 citations
  Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
  Z Bakouny, C Labaki, S Bhalla, A L Schmidt, J A Steinharter, J Cocco, D A Tremblay, M M Awad, A Kessler, R I Haddad, M Evans, F Busser, M Wotman, C R Curran, B S Zimme...> ;Annals of Oncology. 2022 Aug 1
• 6 citations
  Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.
  Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, Nabihah Tayob, Joanna Mercado, Israel Gomy, Anu Chittenden, Sarah Kane, Samantha Stokes, Melissa E Hughes, Ji Seok K...> ;Clinical Cancer Research. 2022 Jun 1
• 5 citations
  State legislative trends related to biomarker testing.
  Gelareh Sadigh, Hilary Gee Goeckner, Ella A Kazerooni, Bruce E Johnson, Robert A Smith, Devon V Adams, Ruth C Carlos> ;Cancer. 2022 Aug 1
• 3 citations
  Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With-Mutated Advanced NSCLC.
  Bruce E Johnson, Christina S Baik, Julien Mazieres, Harry J M Groen, Barbara Melosky, Jürgen Wolf, Fatemeh Asad Zadeh Vosta Kolaei, Wen-Hsing Wu, Stefanie Knoll, Merye...> ;JTO Clinical and Research Reports. 2022 May 1
• Join now to see all

Journal Articles

• Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer Population  
  Khanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation

Lectures

• Welcome and Introductions 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/1/2019